Gemini Fund Services - Performance

Fund Prices & YTD Returns as of 2/15/2019				Performance Through 2/15/2019				Average Annual Returns Through 12/31/2018
NAV	NAV Daily Change	% Daily Change⁽¹⁾	% YTD Return⁽²⁾	One Month	Three Months	Six Months	Since Inception⁽⁴⁾	One Year	Three Years	Five Years	Since Inception⁽⁴⁾
13D Activist Fund Class A
20.44	0.18	0.89%	14.51%	8.09%	3.49%	-3.71%	13.40%	-13.70%	8.30%	5.39%	11.48%
13D Activist Fund Class A
With Sales Charge⁽³⁾				1.89%	-2.43%	-9.25%	12.46%	-18.65%	6.18%	4.15%	10.54%
13D Activist Fund Class I
20.86	0.17	0.82%	14.49%	8.08%	3.52%	-3.60%	13.69%	-13.47%	8.59%	5.66%	11.77%
S&P 500 TR
N/A	0	N/A	11.02%	6.54%	2.20%	-0.50%	14.20%	-4.38%	9.26%	8.49%	12.78%
13D Activist Fund Class C
20.23	0.17	0.85%	14.42%	8.07%	3.27%	-4.06%	11.44%	-14.37%	7.50%	4.61%	9.23%
With Sales Charge⁽³⁾				7.07%	2.27%	-4.98%	11.44%	-15.19%	7.50%	4.61%	9.23%
S&P 500 TR
N/A	0	N/A	11.02%	6.54%	2.20%	-0.50%	13.69%	-4.38%	9.26%	8.49%	12.04%

(1)Represents the percentage increase/decrease in the net asset value from the prior trading day.

(2)Performance for periods less than one year is not annualized.

(3)The maximum sales charge for Class A Shares is 5.75%. Class A Share investors may be eligible for a reduction in sales charges. The Sales Charge (CDSC) performance for Class C shares includes a 1% CDSC on C shares redeemed within 12 months of purchase.

(4) Inception date of the Class A & I shares is December 28, 2011 and December 11, 2012 for Class C.

The total annual fund operating expense ratio is 1.76% for Class A, 2.51% for Class C and 1.51 % for Class I.The performance data quoted here represents past performance. Current performance may be lower or higher than the performance data quoted above. Investment return and principal value will fluctuate, so that shares, when redeemed, may be worth more or less than their original cost. Past performance is no guarantee of future results. A Fund's performance, especially for very short periods of time, should not be the sole factor in making your investment decisions. For performance information current to the most recent month end, please call toll-free 1-877-413-3228.